The Cancer Clinical Research Hospital Program funds research projects whose objectives are:
measuring the effectiveness of health technologies. With this objective in mind, the research that is funded as a priority is that which will contribute to obtaining high-grade recommendations (high-powered randomized controlled trials, meta-analyses of randomized controlled trials).
evaluation of the safety, tolerance or feasibility of the use of health technologies in humans (examples: phase I and I/II studies, phase IV studies).
The selection will be done in 2 phases:
Letter of Intent - deadline for submission September 23, 2021 - 6:00 p.m.
Complete applications for pre-selected projects only - deadline February 17, 2022 - 6:00 pm